Dulski, J.; Heckman, M.G.; White, L.J.; Żur-Wyrozumska, K.; Lund, T.C.; Wszolek, Z.K.
Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: Retrospective Study on Predictors of Outcomes. Pharmaceutics 2022, 14, 2778.
https://doi.org/10.3390/pharmaceutics14122778
AMA Style
Dulski J, Heckman MG, White LJ, Żur-Wyrozumska K, Lund TC, Wszolek ZK.
Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: Retrospective Study on Predictors of Outcomes. Pharmaceutics. 2022; 14(12):2778.
https://doi.org/10.3390/pharmaceutics14122778
Chicago/Turabian Style
Dulski, Jarosław, Michael G. Heckman, Launia J. White, Kamila Żur-Wyrozumska, Troy C. Lund, and Zbigniew K. Wszolek.
2022. "Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: Retrospective Study on Predictors of Outcomes" Pharmaceutics 14, no. 12: 2778.
https://doi.org/10.3390/pharmaceutics14122778
APA Style
Dulski, J., Heckman, M. G., White, L. J., Żur-Wyrozumska, K., Lund, T. C., & Wszolek, Z. K.
(2022). Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: Retrospective Study on Predictors of Outcomes. Pharmaceutics, 14(12), 2778.
https://doi.org/10.3390/pharmaceutics14122778